TABLE 4

Regional BPND Values from Parametric Maps

SRTMSRTM2
RegionAverage*ΔBPNDICCAverage*ΔBPNDICC
Caudate2.0 ± 0.1 (7%)−3% ± 9% (8%)0.92 (0.68; 0.98)1.9 ± 0.2 (10%)−3% ± 10% (9%)0.91 (0.65; 0.98)
Putamen2.6 ± 0.2 (8%)−4% ± 11% (9%)0.63 (−0.01;0.91)2.5 ± 0.2 (9%)−4% ± 11% (9%)0.59 (−0.07; 0.90)
Pallidum3.3 ± 0.5 (15%)−4% ± 11% (7%)0.76 (0.23; 0.95)3.2 ± 0.6 (18%)−5% ± 12% (8%)0.76 (0.24; 0.95)
Ventral striatum3.8 ± 0.4 (10%)−1% ± 11% (9%)0.80 (0.33; 0.96)3.5 ± 0.5 (13%)−2% ± 12% (8%)0.80 (0.34; 0.96)
Amygdala0.32 ± 0.07 (23%)−11% ± 24% (21%)0.32 (−0.40; 0.81)0.27 ± 0.08 (28%)−12% ± 28% (24%)0.30 (−0.42; 0.80)
SN1.8 ± 0.3 (16%)−9% ± 12% (11%)0.94 (0.77; 0.99)1.6 ± 0.4 (24%)−11% ± 14% (12%)0.95 (0.79; 0.99)
Thalamus0.40 ± 0.12 (29%)−1% ± 21% (15%)0.71 (0.14; 0.93)0.36 ± 0.09 (25%)−1% ± 20% (15%)0.50 (−0.20; 0.87)
Hypothalamus1.6 ± 0.6 (36%)−8% ± 22% (17%)0.54 (−0.15; 0.88)1.3 ± 0.6 (46%)−9% ± 21% (16%)0.61 (−0.05; 0.91)
  • * n = 5 HCs; data are presented as mean ± SD (relative SD) across subjects.

  • n = 8 subjects; data are presented as m(∆BPND) ± σ(∆BPND) (m(|∆BPND|)).

  • n = 8 subjects; ICC is presented as estimate, with lower and upper bounds of 95% confidence interval in parentheses.